TrialBritish journal of clinical pharmacology2018

Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Mikiko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.